Found: 2
Select item for more details and to access through your institution.
Impaired virus‐specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 4, p. 554, doi. 10.1002/hon.2769
- By:
- Publication type:
- Article
Ruxolitinib treatment and risk of B‐cell lymphomas in myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 7, p. E185, doi. 10.1002/ajh.25489
- By:
- Publication type:
- Article